Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 8.704% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a Cc1ccc(-n2c(N)cc(=O)nc2SCC(=O)NC2CCCCC2)cc1C
b CC1(C)C[C@H](O)[C@]2(CO)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)[C@@H]2C1
Answer: a. Cc1ccc(-n2c(N)cc(=O)nc2SCC(=O)NC2CCCCC2)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(-n2c(N)cc(=O)nc2SCC(=O)NC2CCCCC2)cc1C
Cc1ccc(-n2c(N)cc(=O)nc2SCC(=O)NC2CCCCC2)cc1C
2-[6-amino-1-(3,4-dimethylphenyl)-4-oxopyrimidin-2-yl]sulfanyl-N-cyclohexylacetamide